References
- Andre P. Hyaluronic acid and its use as a ‘rejuvenation’ agent in cosmetic dermatology. Semin Cutan Med Surg. 2004; 23:218–222.
- Carruthers A, Carruthers J. Non-animal-based hyaluronic acid fillers: Scientific and technical considerations. Plast Reconstr Surg. 2007;120(suppl):33S.
- Wang F, Garza LA, Kang S, Varani J, Orringer JS, Fisher GJ, . In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol. 2007;143:155–163.
- Richter AW, Ryde EM, Zetterstrom EO. Nonimmunogenicity of a purified sodium hyaluronate preparation in man. Int Arch Allergy Appl Immunol. 1979;59:45–48.
- Larsen NE, Pollak CT, Reiner K, Leshchiner E, Balazs EA. Hylan gel biomaterial: Dermal and immunologic compatibility. J Biomed Mater Rev. 1993;27:1129–1134.
- Friedman PM, Mafong EA, Kauvar AN, Geronemus RG. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg. 2002;28: 491–494.
- Hamilton RG, Strobos J, Adkinson NF Jr. Immunogenicity studies of cosmetically administered nonanimal-stabilized hyaluronic acid particles. Dermatol Surg. 2007;33(S2): S176–S185.
- Dover JS, Carruthers A, Carruthers J, Alam M. Clinical use of Restylane. Skin Therapy Lett. 2005;10:5–7.
- Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003; 29:588–595.
- Rao J, Chi GC, Goldman MP. Clinical comparison between two hyaluronic acid-derived fillers in the treatment of nasolabial folds: Hylaform versus Restylane. Dermatol Surg. 2005;31:1587–1590.
- Beer K. A randomized, evaluator-blinded comparison of efficacy of hyaluronic acid gel and avian-sourced Hylan B Plus gel for correction of nasolabial folds. Dermatol Surg. 2007;33:928–936.
- Narins RS, Dayan SH, Brandt FS, Baldwin EK. Persistence and improvement of nasolabial fold correction with nonanimal-stabilized hyaluronic acid 100,000 gel particles/mL filler on two retreatment schedules: results up to 18 months on two retreatment schedules. Dermatol Surg. 2008;34:S2–S8.
- Narins RS, Brandt FS, Lorence ZP, Maas CS, Monheit GD, Smith SR, . A randomized, multicenter study of the safety and efficacy of Dermicol-P35 and nonanimal-stabilized hyaluronic acid gel for the correction of nasolabial folds. Dermatol Surg. 2007;33(S2):S213–S221.
- Baumann LS, Shamban AT, Lupo MP, Monheit GD, Thomas JA, Murphy DK, . Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: A multicenter, double-masked, randomized, within-subject study. Dermatol Surg. 2007;33:S128–S135.
- Matarasso SL, Carruthers JD, Jewell ML the Restylane Consensus Group. Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane). Plast Reconstr Surg. 2006;117(3 suppl): 3S–34S.
- Glogau RG, Kan MA. Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid dermal fillers. Dermatol Surg. 2008; 34:S105–S109.